HTG MOLECULAR DIAGNOSTICS, INC Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Htg Molecular Diagnostics, Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
  • Htg Molecular Diagnostics, Inc Operating Lease, Payments for the quarter ending March 31, 2023 was $130K, a 10.5% increase year-over-year.
  • Htg Molecular Diagnostics, Inc annual Operating Lease, Payments for 2022 was $488K, a 5.21% decline from 2021.
  • Htg Molecular Diagnostics, Inc annual Operating Lease, Payments for 2021 was $514K, a 41.8% decline from 2020.
  • Htg Molecular Diagnostics, Inc annual Operating Lease, Payments for 2020 was $883K, a 14.6% increase from 2019.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $488K -$26.8K -5.21% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 $514K -$369K -41.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $883K +$113K +14.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $771K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.